Introduction
============

The chicken DT40 B lymphocyte cell line provides a unique opportunity to analyze the role of individual DNA polymerases in homologous recombination (HR) and translesion DNA synthesis (TLS) because DT40 cells diversify Ig V genes through HR (Ig gene conversion) and nontemplated single-nucleotide substitutions (Ig hypermutation) during in vitro culture ([@bib9]; [@bib44]). Ig gene conversion introduces tracts of templated mutations derived from an array of pseudo-V~λ~ (ΨV~λ~) regions, located upstream of rearranged VJ~λ~, to the V~λ~ segment of the rearranged VJ~λ~ ([@bib39]). Because donor and recipient segments have an ∼10% sequence divergence, sequential Ig gene conversion events are able to substantially diversify the Ig V gene. However, Ig hypermutation is performed by TLS past abasic sites in DT40 cells ([@bib53]; [@bib2]; [@bib42]).

Activation-induced deaminase (AID) is responsible for triggering Ig hypermutation and Ig gene conversion ([Fig. 1](#fig1){ref-type="fig"}; [@bib1]; [@bib14]). AID catalyses deoxycytidine to generate uracil followed by elimination of uracil by uracil glycosylase to induce abasic sites ([@bib11]; [@bib37]). Replication blockages at abasic sites generated at the V(D)J segment and subsequent release from the blockage by HR and TLS may cause Ig gene conversion and Ig hypermutation, respectively, in DT40 cells ([Fig. 1](#fig1){ref-type="fig"}; [@bib53]; [@bib42]; [@bib28]). In Ig gene conversion, replication blockage may induce template switch from the V(D)J segment to pseudo-V segments. Subsequent DNA synthesis using pseudo-V segments as a template may lead to gene conversion from the pseudo-V segments to the V(D)J segment ([@bib7]). Collectively, determination of Ig V nucleotide sequences in DT40 cells provides a unique opportunity to identify both the gene conversion tracts and the spectrum of TLS-dependent mutations. This allows identification of the DNA polymerases involved in these Ig V diversification reactions.

![**Molecular mechanisms for Ig gene diversification, yielding substitutions at C/G pairs and Ig gene conversion in DT40 cells.** AID-mediated deamination of C generates a U/G mispair. Uracil DNA glycosylase (UNG) can excise the U residue to generate an abasic site (AP), which causes replication blockage. (bottom right) Release of replication blockage by TLS causes mutations at C/G pairs, depending on which nucleotide is inserted opposite the abasic site. (bottom left) Alternatively, HR-dependent template switch from V(D)J segment to pseudo-V genes induces Ig gene conversion. Colored boxes indicate pseudo-V genes. DNA polymerases with a previously identified role in Ig gene diversification are shown in black ([@bib17]; [@bib34]; [@bib40]; [@bib42]), and those identified in this study are shown in red. This figure is based on previously described results ([@bib43]; [@bib7]).](JCB_200912012R_RGB_Fig1){#fig1}

HR is a multistep process that repairs double-strand breaks (DSBs) and releases replication blockage using intact homologous sequences as a template ([@bib35]; [@bib59]; [@bib57]). DSBs are processed during the early steps of HR, leading to the formation of 3′ single-strand overhangs, which associate with polymerized Rad51. The resulting complex, including the 3′ overhangs and Rad51, invades intact homologous duplex DNA to form a D loop structure. DNA synthesis from the invading 3′ overhang, followed by the recapture of the newly synthesized DNA strand by the other end of the DSB, completes DSB repair. This type of HR is called synthesis-dependent strand annealing and does not cause the generation of crossover DNA. Because the D loop is unstable, efficient DNA synthesis may significantly increase the rate of gene conversion ([@bib36]). DNA synthesis can be performed by DNA polymerases η and ζ (Polη and Polζ; [@bib55]; [@bib17]; [@bib26]), although other DNA polymerases may also contribute to HR. Another unresolved question concerns the nature of the DNA polymerases that are involved in HR-dependent release of replication blockage.

Computational analysis of the human genome revealed genes encoding two A-type DNA polymerases, *POLN* ([@bib23]) and *POLQ* ([@bib47], [@bib48]), in addition to the *POLG* gene, a unique DNA polymerase found in mitochondria. *POLQ*, but not *POLN*, contains a helicase domain near its N terminus, as does *MUS308*, the prototype orthologue of *POLN/POLQ* in *Drosophila melanogaster* ([@bib6]). Subsequent biochemical studies have shown that Polν and Polθ, which lack intrinsic exonucleolytic proofreading activity, can indeed perform TLS past abasic sites, undergo DNA synthesis with very low fidelity, and extend from mismatches ([@bib48]; [@bib56]; [@bib3], [@bib4]; [@bib46]). Genetic studies have addressed the function of *POLN* and *POLQ* using *D. melanogaster*, mice, and chicken DT40 cells ([@bib6]; [@bib51]; [@bib60]). *D. melanogaster* deficient in *MUS308* are hypersensitive to chemical cross-linkers, indicating the critical role played by the A-type polymerases in DNA damage response ([@bib6]). However, phenotypic analysis of both *POLN^−/−^/POLQ^−/−^* DT40 cells and *POLQ^−/−^* mice cells shows that Polν and Polθ do not play the same critical role as Mus308 in cellular responses to chemical cross-linkers, and Polθ makes significant contributions to the DNA repair of base damage and probably to TLS ([@bib51]; [@bib60]).

We examined Ig V diversification in *POLN^−/−^*, *POLQ^−/−^*, and *POLN^−/−^/POLQ^−/−^* DT40 clones. Compared with wild-type cells, *POLN^−/−^/POLQ^−/−^* DT40 cells exhibited a significant reduction in the rate of Ig gene conversion, which was associated with increased length of gene conversion but not Ig hypermutation rate. This observation is in marked contrast to the absence of prominent defects in *POLN^−/−^/POLQ^−/−^* cells in general HR, including gene targeting and camptothecin sensitivity. Moreover, *POLN^−/−^/POLQ^−/−^* clones showed significant reduction in the number of C to G mutations, indicating that Polν and Polθ play a role in TLS past the abasic site. Because Polη is involved in Ig hypermutation and Ig gene conversion ([@bib17]), we disrupted the *POLH* gene in the *POLN^−/−^/POLQ^−/−^* background. Ig hypermutation rate was significantly decreased in the resulting *POLH^−/−^/POLN^−/−^/POLQ^−/−^* cells. Remarkably, no Ig gene conversion events were detectable in *POLH^−/−^/POLN^−/−^/POLQ^−/−^* cells, indicating that the three DNA polymerases were responsible for Ig gene diversification ([Fig. 1](#fig1){ref-type="fig"}). Only *POLH^−/−^/POLN^−/−^/POLQ^−/−^* cells showed increased sensitivity to camptothecin, a topoisomerase I inhibitor. In conclusion, Polν and Polθ may have adapted to perform a specialized function for Ig V diversification and can contribute to HR-dependent repair only when other HR-related DNA polymerases are absent.

Results
=======

Cells deficient in *POLN* and *POLQ* exhibit a decrease in the rate of Ig gene conversion
-----------------------------------------------------------------------------------------

To investigate the role of Polν and Polθ in Ig gene diversification, we induced Ig gene conversion and Ig hypermutation by ectopically expressing AID in *POLN^−/−^*, *POLQ^−/−^*, *POLN^−/−^/POLQ^−/−^*, and wild-type DT40 cells through retrovirus infection ([@bib52]; [@bib42]). We determined the VJ~λ~ nucleotide sequences of more than three clonally expanded populations from each genotype. The overexpression of the AID transgene increased the rate of Ig gene conversion in wild-type cells by 17-fold to 9.8 × 10^−3^ per nucleotide per division ([Fig. 2, A and B](#fig2){ref-type="fig"}; and [Fig. 3 C](#fig3){ref-type="fig"}). *POLH^−/−^* cells showed a decrease in Ig gene conversion rate as we have previously shown ([@bib17]). Wild-type, *POLN^−/−^*, and *POLQ^−/−^* clones exhibited indistinguishable rates of Ig gene conversion, whereas the rate of Ig gene conversion in *POLN^−/−^/POLQ^−/−^* cells is 4.9 times lower than in wild-type cells (P \< 0.0002; [Fig. 2 C](#fig2){ref-type="fig"} and [Fig. 3 C](#fig3){ref-type="fig"}). This finding reveals an unexpected function of Polν and Polθ in HR ([Fig. 1](#fig1){ref-type="fig"}). Moreover, the synergistic effect of *POLN* and *POLQ* mutations on the Ig gene conversion rate indicates that Polν and Polθ may complement each other in HR-dependent Ig V diversification.

![**Nucleotide sequence analysis of VJ~λ~ segments to detect Ig gene conversions and nontemplated point mutations.** (A) VJ~λ~ segments isolated from wild-type cells, clonally expanded for 3 wk. Each horizontal line represents the analyzed 430 bp VJ~λ~, showing point mutations (lollipop shape) and Ig gene conversion tracts (horizontal bar above line). The numbers at the bottom indicate the number of nucleotides from the 76th base of the intronic sequence between leader and variable exons. (B) VJ~λ~ segments from clonally expanded cells carrying the indicated genotype at 2 wk after AID virus infection. O/E, ectopic overexpression of AID. Data are displayed as in A. Numbers of analyzed VJ~λ~ sequences are as follows: wild type, 29; *POLH^−/−^*, 43; *POLQ^−/−^*, 34; *POLN^−/−^*, 48; *POLN^−/−^/POLQ^−/−^* \#1, 59; *POLN^−/−^/POLQ^−/−^* \#2, 60; and *POLH^−/−^/POLN^−/−^/POLQ^−/−^*, 49. (C) Proportion of VJ~λ~ sequences indicating the number of Ig hypermutations (PM), Ig gene conversions (GC), and mutations of ambiguous origin (Amb; either hypermutations or gene conversions; see Materials and methods) at 2 wk after AID virus infection. Segment sizes are proportional to the number of sequences, indicated by the number of mutations (numbers around the perimeter of the pie charts). Data from *POLN^−/−^/POLQ^−/−^* \#1 and *POLN^−/−^/POLQ^−/−^* \#2 clones were combined and shown as a *POLN^−/−^/POLQ^−/−^* AID-overexpressing sample.](JCB_200912012R_RGB_Fig2){#fig2}

![**Nucleotide substitution preferences and rate of Ig hypermutation, Ig gene conversion, and mutations of ambiguous origin at 2 wk after AID virus infection in wild-type and mutant cells.** (A) Nucleotide substitution preferences deduced from Ig hypermutation in the VJ~λ~ sequences (seq) of cells carrying the indicated genotype at 2 wk after AID virus infection. O/E, ectopic overexpression of AID. (B) AID-induced nucleotide substitution preferences from ambiguous (Amb) mutations, which are attributable to either Ig hypermutation or Ig gene conversion, are shown. (C) Rate of Ig hypermutation (PM), Ig gene conversion (GC), and mutations of ambiguous origin at 2 wk after AID virus infection. Error bars indicate SEM.](JCB_200912012_RGB_Fig3){#fig3}

We next evaluated the contribution of Polν and Polθ to Ig gene conversion without overexpressing AID. We generated *POLN^−/−^*, *POLQ^−/−^*, and *POLN^−/−^/POLQ^−/−^* cells from surface IgM (sIgM)--negative wild-type cells carrying a +G frameshift mutation in the rearranged VJ~λ~ segment at the same site as in the CL18 clone ([Fig. 4 A](#fig4){ref-type="fig"} and [Fig. 5 B](#fig5){ref-type="fig"}; [@bib9]). We monitored the gain of sIgM expression resulting from the Ig gene conversion--mediated elimination of the frameshift mutation. We measured sIgM gain fluctuation using subclones derived from a single sIgM-negative cell after 3 wk of clonal expansion. Because sIgM gain was hardly detectable in the *POLN^−/−^* or *POLQ^−/−^* cells ([Fig. 4 B](#fig4){ref-type="fig"}), we augmented the rate of Ig gene conversion by treating cells with trichostatin A (TSA), a histone deacetylase inhibitor. TSA increases Ig gene conversion 50-fold without inducing Ig hypermutation, probably by relaxing the local chromatin structure specifically at the ψV segments and thereby promoting the interaction between the ψV donor segments and V(D)J segments ([@bib50]; [@bib28]). When compared with wild-type cells, the *POLN^−/−^* and *POLQ^−/−^* cells exhibited a significant decrease in the appearance of sIgM-positive revertant fractions ([Fig. 4 C](#fig4){ref-type="fig"}). It should be noted that such a decrease was not observed in AID-overexpressing cells ([Fig. 3 C](#fig3){ref-type="fig"}). This apparent discrepancy might be explained by the idea that the rate-limiting step of Ig gene conversion may be the interaction between the ψV segments and V(D)J segments in AID-overexpressing cells, whereas a subsequent DNA synthesis step may be rate limiting in TSA-treated cells. Thus, a compromised DNA synthesis step in *POLN^−/−^* and *POLQ^−/−^* cells may cause significant decreases in the rate of gene conversion only in TSA-treated cells but not in AID-overexpressing cells. In addition to significantly reduced Ig gene conversion in *POLN^−/−^* and *POLQ^−/−^* cells, remarkably, the reversion fraction was nearly undetectable in the *POLN^−/−^/POLQ^−/−^* cells ([Fig. 4 C](#fig4){ref-type="fig"}).

![**Analysis of Ig gene conversion rate measured by sIgM gain.** (A) Diagram of Ig gene conversion assay for DT40 cells. The frameshift mutation caused by the insertion of G in the rearranged V~λ~ segment in the parent cells is indicated by the circle. Gene conversion events using an upstream ΨV donor segment can eliminate the frameshift mutation, resulting in a gain in sIgM expression. The ΨV segment is indicated by the shaded box. (B) The kinetics of Ig gene conversion is evaluated by measuring the frequency of sIgM gain. The frequency of sIgM gain revertants of the indicated genotype was determined at 3 wk without TSA. We determined the percentage of sIgM gain variants from the following number of sIgM-negative subclones: wild type, 35; *POLQ^−/−^*, 22; *POLN^−/−^*, 13; and *POLN^−/−^/POLQ^−/−^*, 34. Wild-type data were described previously ([@bib17]; [@bib28]). The horizontal bars in the panel indicate median percents. (C) The frequency of sIgM gain revertants of the indicated genotype was determined at 3 wk after addition of 1.25 ng/ml TSA. We determined the percentage of sIgM gain variants from the following number of sIgM-negative subclones: wild type, 14; *POLQ^−/−^*, 9; *POLN^−/−^*, 10; and *POLN^−/−^/POLQ^−/−^*, 6. (D) The frequency of sIgM gain revertants was determined at 3 wk after addition of 1.25 ng/ml TSA in *POLN^−/−^* clones reconstituted with human *POLN* cDNA. We determined the percentage of sIgM gain variants from the following number of sIgM-negative subclones: wild type, 39; *POLN^−/−^*, 10; and *POLN^−/−^* + *hPOLN*, 12.](JCB_200912012R_GS_Fig4){#fig4}

![**Increased length of Ig gene conversion tracts in *POLN^−/−^/POLQ^−/−^* cells.** (A) Primary structure of the chicken Ig V~λ~ gene is shown. There are 25 ΨV~λ~ segments upstream of a single functional VJ~λ~ segment. (B) Nucleotide sequences around the frameshift (bolded G nucleotide) of the recipient V~λ~ segment. The maximum gene conversion tract in sIgM-positive revertant cells is indicated by the bolded line. Shaded letters indicate mismatches between donor ΨV~8~ and recipient ΨV~λ~. The donor ΨV~8~ and recipient VJ are green and red, respectively. In the converted sequences, donor- and recipient-derived nucleotides are also colored green and red, respectively, whereas sequences derived from either donor or recipient are blue. Thus, gene conversion is initiated and terminated somewhere within the blue sequences flanking the green 146th T nucleotide. The numbers shown above the sequences indicate the nucleotide numbers in the V~λ~ exon. (C) Comparison of gene conversion tract spectra in the ΨV~λ~ segment rearranged with ΨV~8~ in sIgM-positive revertants from three independent clones derived from wild-type, *POLQ^−/−^*, *POLN^−/−^*, and *POLN^−/−^/POLQ^−/−^* cells at 3 wk after TSA treatment. Conversion tract length can be estimated by the distance between the nucleotides at the mismatched sites in the donor and recipient DNA. The sequence shared by both the donor ΨV~8~ and the recipient gene is indicated by the shaded boxes. Crossover sites must be within these boxes. The dotted vertical lines indicate the position of mismatches between donor ΨV~8~ and recipient ΨV~λ~ (these positions are 48, 97, 108, 145, 172, 182, 222, 237, and 304 bases from the 76th base of the intron between the leader and the V~λ~ exons). Black triangles indicate the position of the frameshift (corresponding to the bolded G in B) of the recipient VJ segment. The number of analyzed ΨV~λ~ segments rearranged with the ΨV~8~ donor in wild-type, *POLQ^−/−^*, *POLN^−/−^*, and *POLN^−/−^/POLQ^−/−^* cells was 20, 39, 30, and 17, respectively.](JCB_200912012R_RGB_Fig5){#fig5}

To confirm the role of Polν in Ig gene conversion, we reconstituted *POLN^−/−^* cells with the human *POLN* transgene ([@bib56]). The *POLN* transgene rescued the rate of Ig gene conversion to a level comparable with that of wild-type cells ([Fig. 4 D](#fig4){ref-type="fig"}), confirming an important role for Polν in Ig gene conversion. When taken together, nucleotide sequence analysis of Ig V~λ~ in AID-overexpressing cells ([Fig. 3](#fig3){ref-type="fig"}) and measurement of sIgM gain ([Fig. 4](#fig4){ref-type="fig"}) indicate the involvement of both Polν and Polθ in Ig gene conversion ([Fig. 1](#fig1){ref-type="fig"}).

Increased length of gene conversion tracts in *POLN^−/−^/POLQ^−/−^* cells
-------------------------------------------------------------------------

To assess the nature of Ig gene conversion events, we examined the type of Ig gene conversion that causes sIgM gain. We sorted sIgM-positive cells from three clonally expanded populations from each genotype. To measure the length of the gene conversion tracts, we analyzed those tracts where the +G frameshift mutation of the rearranged VJ~λ~ segment ([@bib9]) is replaced by the ψV~8~ donor segment ([Fig. 5 A](#fig5){ref-type="fig"}). To achieve this, we subcloned each genotype, cultured individual subclones in the presence of TSA, sorted sIgM-positive revertants at 3 wk, and determined the nucleotide sequence in the VJ~λ~ segment. The sequences around the parental frameshift mutation were replaced by ψV~8~ in most of the VJ~λ~ segments analyzed, presumably because the VJ~λ~ segment around the frameshift mutation has the highest sequence similarity (92.4%) to the ψV~8~ segment ([@bib9]).

The length of the gene conversion tract involving ψV~8~ was estimated as reported previously for the analysis of *POLH^−/−^* cells ([@bib17]). Conducting a sequence comparison between (a) a pseudo-V~8~ (donor), (b) the VJ~λ~ segment containing the frameshift mutation (recipient), and (c) their converted sequences ([Fig. 5 B](#fig5){ref-type="fig"}) enabled us to determine which sequences in the recipient were replaced by which donor in each product. For example, sequence analysis of tracts in wild-type cells indicated that the 5′-TAC**G**GCT-3′ sequences in the recipient were replaced by ψV~8~-derived 5′-TATGCT-3′ sequences in all analyzed products ([Fig. 5 B](#fig5){ref-type="fig"}; note that the bolded G causes the frameshift and corresponds to the black triangle in [Fig. 5 C](#fig5){ref-type="fig"}). Thus, the C**G** of the recipient is replaced by the T of the donor through Ig gene conversion, which restores the reading frame of the Ig V~λ~ gene. These converted sequences were flanked by identical sequences that were shared by all donor, recipient, and converted sequences ([Fig. 5 B](#fig5){ref-type="fig"}, blue). Outside this region of ∼80 nucleotides, there are occasional mismatches, indicated by the gray shading in [Fig. 5 B](#fig5){ref-type="fig"} and by the dotted lines in [Fig. 5 C](#fig5){ref-type="fig"}.

We were able to define a minimum tract length (distance between the furthest mismatched nucleotides in the Ig gene conversion product and recipient) and a maximum tract length (distance between the closest mismatched nucleotides in the Ig gene conversion product and donor; [Fig. 5 C](#fig5){ref-type="fig"}). We confirmed that the starting sequences of the frameshift in wild-type and each mutant were identical ([Fig. S1](http://www.jcb.org/cgi/content/full/jcb.200912012/DC1)). We next calculated the maximum length of the gene conversion tract for each genotype. 25% of the analyzed gene conversion tracts contained the donor sequences at the two mismatches, the 48th and 182nd nucleotides in the wild-type clones. This result defines the maximum length of the conversion tract in wild-type cells (134 nucleotides). Likewise, 3% of the gene conversion tracts exhibited a maximum length of 125 nucleotides in the *POLN^−/−^* cells. Remarkably, the *POLN^−/−^/POLQ^−/−^* clones exhibited a dramatic increase in the length of the gene conversion tract compared with cells carrying the other genotypes, with 88% of the gene conversion tracts exhibiting a maximum length of 256 nucleotides. Tract length in *POLN^−/−^/POLQ^−/−^* clones is statistically longer than that of *POLQ^−/−^* clones, and *POLN^−/−^/POLQ^−/−^* clones have the longest tract (242 vs. 116; P \< 0.01). Moreover, all of the gene conversion tracts exhibited a longer minimum length in three subclones derived from the *POLN^−/−^/POLQ^−/−^* cells than in the wild-type cells. These results suggest that other unidentified polymerases may carry out DNA synthesis with higher processivity in the absence of Polν and Polθ and thereby significantly increase the length of the gene conversion tracts in *POLN^−/−^/POLQ^−/−^* cells ([Fig. 5 C](#fig5){ref-type="fig"}).

No detectable Ig gene conversion events in *POLH^−/−^/POLN^−/−^/POLQ^−/−^* cells
--------------------------------------------------------------------------------

Because both *POLN^−/−^/POLQ^−/−^* and *POLH^−/−^* DT40 clones exhibited a significant decrease in the rate of Ig gene conversion, we wanted to explore the functional redundancy between the two A-type DNA polymerases and Polη. To this end, we disrupted the *POLH* gene in two independently isolated *POLN^−/−^/POLQ^−/−^* clones. The resulting three *POLH^−/−^/POLN^−/−^/POLQ^−/−^* clones consistently showed a marked retardation of cellular proliferation ([Fig. 6 A](#fig6){ref-type="fig"}) accompanied by increased levels of spontaneous chromosomal aberrations ([Fig. 6 B](#fig6){ref-type="fig"}). Thus, the three DNA polymerases functionally overlap in terms of the maintenance of chromosomal DNA. We next measured Ig gene conversion in *POLH^−/−^/POLN^−/−^/POLQ^−/−^* clones. Remarkably, we were not able to detect any Ig V gene conversion tracts in *POLH^−/−^/POLN^−/−^/POLQ^−/−^* clones ([Fig. 2 C](#fig2){ref-type="fig"} and [Fig. 3 C](#fig3){ref-type="fig"}). Moreover, ambiguous A/T mutations, which are products of HR ([@bib42]), were abolished in the *POLH^−/−^/POLN^−/−^/POLQ^−/−^* cells ([Fig. 3 B](#fig3){ref-type="fig"}). These observations demonstrate that these three error-prone DNA polymerases are sufficient for all Ig gene conversion events in DT40 cells.

![***POLH^−/−^/POLN^−/−^/POLQ^−/−^* cells displayed growth retardation, chromosomal aberrations, and hypersensitivity to chemotherapeutic agent.** (A) Growth curve for cells of the indicated genotype. (B) Spontaneous chromosomal aberrations per 50 cells in the indicated genotype. (C) Cells carrying the indicated genotype were exposed to camptothecin. (D) Cells carrying the indicated genotype were exposed to cisplatin. Doses are displayed on the x axes on a linear scale, and the fractions of surviving colonies are displayed on the y axes on a logarithmic scale. Error bars show the standard error of the mean for at least three independent experiments.](JCB_200912012R_LW_Fig6){#fig6}

HR-dependent repair of *POLN^−/−^/POLQ^−/−^* and *POLH^−/−^/POLN^−/−^/POLQ^−/−^* cells
--------------------------------------------------------------------------------------

Although HR plays a key role in cellular tolerance to cisplatin ([@bib29]), *POLN^−/−^/POLQ^−/−^* cells exhibit a normal tolerance to chemical cross-linking agents ([@bib60]). The apparent discrepancy between this observation and the important role played by Polν and Polθ in Ig gene conversion led us to reevaluate the efficiency of HR reactions in cells deficient in *POLN* and *POLQ*. To this end, we measured the frequency of gene targeting ([Table I](#tbl1){ref-type="table"}) and cellular tolerance to cisplatin and camptothecin, a topoisomerase I poison ([Fig. 6, C and D](#fig6){ref-type="fig"}), and the HR-dependent repair of ISceI restriction enzyme--induced DSBs ([Fig. 7](#fig7){ref-type="fig"}).

###### 

Targeted integration frequencies

  Genotype                *OVALBMIN* locus   *POLK* locus
  ----------------------- ------------------ --------------
  Wild type               18/19 (95%)        2/23 (8.7%)
  *POLQ^−/−^*             20/21 (95%)        ND
  *POLN^−/−^*             22/23 (96%)        8/51 (16%)
  *POLN^−/−^/POLQ^−/−^*   29/31 (94%)        1/10 (10%)

Wild-type and knockout cells were transfected with targeting constructs of the indicated genotype. The number of targeted clones/number of drug-resistant clones analyzed is shown.

![**The role of Polν and Polθ in HR-dependent repair of ISceI-mediated DSBs.** (A) The diagram shows the method of measuring the frequency of HR in an artificial substrate DNA, SCneo. The expression vector encoding the ISceI restriction enzyme was transiently transfected into cells carrying SCneo in the *OVALBUMIN* locus. Shaded and white boxes represent the S2neo and 3′neo genes, respectively (not to scale). Successful gene conversion from 3′neo to S2neo reconstitutes the functional neomycin resistance gene. (B) Results of an ISceI-induced gene conversion assay for the indicated genotypes are shown. The histogram shows the frequency of HR-dependent DSB repair, which is estimated by measuring the frequency of neomycin-resistant colonies per cell. Error bars show the standard error of the mean for at least three independent experiments.](JCB_200912012_GS_Fig7){#fig7}

Camptothecin stabilizes a complex of topoisomerase I covalently linked to nicked DNA. This complex interrupts replication and causes DSBs in one of the sister chromatids. These DSBs are repaired exclusively by HR using the intact sister chromatid ([@bib15]; [@bib38]; [@bib41]). We found that neither *POLN^−/−^*, *POLQ^−/−^*, nor *POLN^−/−^/POLQ^−/−^* clones exhibited an increased sensitivity to camptothecin ([Fig. 6 C](#fig6){ref-type="fig"}). Likewise, the frequency of targeted integration into the *OVALBUMIN* and the *POLK* locus was not diminished in any of the mutant clones ([Table I](#tbl1){ref-type="table"}). Collectively, although Polν and Polθ play a critical role in Ig gene conversion, these DNA polymerases have little, if any, contribution to HR-mediated repair. Alternatively, the functional overlap between the two A-type DNA polymerases and other DNA polymerases may mask the contribution of Polν and Polθ to HR-dependent repair.

We next explored the functional relationship of Polν and Polθ with Polη in HR-mediated repair. To this end, we measured cellular sensitivity to camptothecin and cisplatin. Intriguingly, the *POLH^−/−^/POLN^−/−^/POLQ^−/−^* cells exhibited an increase in sensitivity to camptothecin, a phenotype that was not shared by the *POLH^−/−^* or *POLN^−/−^/POLQ^−/−^* clones ([Fig. 6 C](#fig6){ref-type="fig"}). These observations reveal that the two A-type DNA polymerases can play a role in general HR only when Polη is deleted. In contrast, *POLH^−/−^/POLN^−/−^/POLQ^−/−^* clones showed a normal sensitivity to cisplatin ([Fig. 6 D](#fig6){ref-type="fig"}). Presumably, other polymerases may have substituted for Mus308, the prototype polymerase of *D. melanogaster*, which plays a critical role in providing a cellular tolerance to cross-linking reagents.

To analyze HR-dependent DSB repair in an artificial substrate, we inserted an HR substrate, SCneo, which carries the rare cutting endonuclease site, ISceI, into the *OVALBUMIN* locus of wild-type and all mutant clones ([@bib16]; [@bib13]). This construct carries two mutant neomycin-resistance genes (S2neo and 3′-neo), which are localized in tandem and are complementary to each other ([Fig. 7 A](#fig7){ref-type="fig"}). After transient expression of ISceI, the induced DSB in S2neo is repaired by HR, with the 3′-neo serving as the donor for gene conversion, leading to the restoration of a functional neomycin resistance gene. Thus, we can measure the frequency of HR-dependent DSB repair by counting the number of neomycin-resistant (neo^R^) colonies. The frequency of HR-dependent repair was decreased three to six times in *POLQ^−/−^*, *POLN^−/−^*, and *POLN^−/−^/POLQ^−/−^* cells in comparison with wild-type cells ([Fig. 7 B](#fig7){ref-type="fig"}). Collectively, Polν and Polθ contribute to some of the HR reactions.

Polν, Polθ, and Polη are involved in TLS-dependent hypermutation at IgV
-----------------------------------------------------------------------

Biochemical studies and our previous study on *POLN^−/−^/POLQ^−/−^* DT40 cells suggest a role for Polν and Polθ in TLS ([@bib49]; [@bib56]; [@bib60]; [@bib3]). To verify this conclusion, we examined nontemplated single-base substitutions (Ig hypermutation) in cells deficient in *POLH*,*POLN*, and*POLQ*. AID overexpression for 2 wk increased the rate of Ig hypermutation from 1.3 × 10^−6^ to 6.3 × 10^−5^ per nucleotide per division ([Fig. 2, A and B](#fig2){ref-type="fig"}; and [Fig. 3 C](#fig3){ref-type="fig"}). The rate of Ig hypermutation exhibited only a modest change in the single- and double-mutant clones when compared with wild-type cells; 1.7 times lower for *POLH^−/−^* cells, 1.4 times higher for *POLQ^−/−^* cells, 1.1 times higher for *POLN^−/−^* cells, and 1.6 times lower for *POLN^−/−^/POLQ^−/−^* cells ([Fig. 2 C](#fig2){ref-type="fig"} and [Fig. 3 C](#fig3){ref-type="fig"}). On the contrary, the rate of Ig hypermutation in wild-type cells is 3.5 times higher than in *POLH^−/−^/POLN^−/−^/POLQ^−/−^* cells ([Fig. 2 C](#fig2){ref-type="fig"} and [Fig. 3 C](#fig3){ref-type="fig"}).

The *POLN^−/−^/POLQ^−/−^* cells showed a marked reduction in the number of C to G mutations when compared with wild-type cells, indicating that Polν and Polθ play a role in TLS past the abasic site (P \< 0.0095; [Fig. 3 A](#fig3){ref-type="fig"}). The C to G, C to T, and G to C mutations tended to also be decreased in *POLH^−/−^/POLN^−/−^/POLQ^−/−^* clones when compared with wild-type cells. These data support the notion that A family DNA polymerases Polν and Polθ, together with Y family DNA polymerase Polη, contribute to TLS-dependent Ig hypermutation in DT40 cells ([Fig. 1](#fig1){ref-type="fig"}).

Discussion
==========

We previously demonstrated that Polθ can play a role in base excision repair and probably in TLS ([@bib60]). In this study, we demonstrate a dominant role played by Polθ and Polν in HR-dependent Ig V gene conversion and in TLS-dependent Ig hypermutation. These DNA polymerases make only a small contribution to HR, as indicated by the normal range of cellular tolerance to the anticancer agents cisplatin and camptothecin and by normal efficiency of gene targeting ([Fig. 6, C and D](#fig6){ref-type="fig"}; and [Table I](#tbl1){ref-type="table"}). Nonetheless, the hypersensitivity of *POLH^−/−^/POLN^−/−^/POLQ^−/−^* cells but not of *POLH^−/−^* or *POLN^−/−^/POLQ^−/−^* cells to camptothecin reveals that the two A-type DNA polymerases can contribute to HR-dependent DNA repair if other HR-related DNA polymerases are not available ([Fig. 6 C](#fig6){ref-type="fig"}). In addition, reduced HR-dependent DSB repair in *POLN^−/−^* and *POLQ^−/−^* cells as well as in Polν-depleted human cells ([@bib64]; [@bib27]) indicates a contribution of Polν and Polθ preferentially to HR in DSB repair ([Fig. 7 B](#fig7){ref-type="fig"}). Conceivably, the choice of DNA polymerases in the DNA synthesis step of HR may be dependent on the type of DNA damage, which may explain why *POLN^−/−^* and *POLQ^−/−^* cells showed defective HR-dependent DSB repair without displaying sensitivity to cisplatin or camptothecin.

Accumulating evidence indicates that individual DNA polymerases can perform multiple roles, e.g., Polκ for nucleotide excision repair and TLS ([@bib30]; [@bib31]), Polη for HR and TLS ([@bib17]), and Polζ for HR and TLS ([@bib55]). Thus, we can also add the role played by Polν and Polθ in HR and TLS to the list of multiple functions performed by individual DNA polymerases.

Polν and Polθ may promote DNA synthesis in Ig gene conversion
-------------------------------------------------------------

Our results support the premise that Polν and Polθ play a role in the DNA synthesis step of HR. First, Ig gene conversion was significantly decreased in *POLN^−/−^/POLQ^−/−^* cells ([Fig. 2 C](#fig2){ref-type="fig"}, [Fig. 3 C](#fig3){ref-type="fig"}, and [Fig. 4 C](#fig4){ref-type="fig"}). Second, this decrease may be associated with a marked increase in the length of the gene conversion tract ([Fig. 5 C](#fig5){ref-type="fig"}). Third, no Ig gene conversion events were detectable in *POLH^−/−^/POLN^−/−^/POLQ^−/−^* clones ([Fig. 2 C](#fig2){ref-type="fig"} and [Fig. 3 C](#fig3){ref-type="fig"}). Therefore, Polη may be responsible for gene conversion events having the longer gene conversion tract. Purified Polη can undergo DNA synthesis using a D loop structure as a template ([@bib26]). Thus, like Polη, the two A-type DNA polymerases may contribute to the DNA synthesis step of Ig gene conversion.

During metazoan evolution, Polν and Polθ appear to have obtained a specialized HR function (HR-dependent Ig V diversification in B lymphocyte precursors), whereas other DNA polymerases may have substituted for Mus308, the prototype DNA polymerase, which plays a critical role in cellular tolerance to DNA-damaging agents. It should be noted that Ig gene conversion is distinctly different from other HR reactions because it allows for recombination between two diverged sequences. In fact, although a 0.1% sequence divergence strongly suppresses HR reactions ([@bib58]), Ig gene conversion is efficiently performed between homeologous sequences with 10% divergence. This divergence may strongly suppress DNA synthesis in the D loop structure such that a mismatch between primer and template strands interferes with DNA synthesis from the primer and also destabilizes the D loop ([@bib16]; [@bib5]). Accordingly, during evolution, Polν and Polθ may have acquired a specialized character suitable for this extremely difficult task, HR-dependent Ig V diversification. Ig gene conversion plays an important role in diversifying Ig V gene not only in chickens but also in the rabbit, whereas primates and rodents rely on V(D)J recombination to diversify Ig V ([@bib21]; [@bib22]). Evidence that Ig gene conversion contributes to Ig V diversification in other mammals such as pig, cattle, sheep, and horses is less convincing ([@bib10]; [@bib63]). Because performing effective DNA synthesis in Ig gene conversion is a difficult challenge for DNA polymerases, this study suggests the critical role played by Polη, Polν, and Polθ in Ig V diversification in some domesticated animals as well as in DT40 cells. Conceivably, vertebrates are faced with more complex tasks, such as acquired immune reactions, in addition to the maintenance of genomic DNA ([Fig. 6 B](#fig6){ref-type="fig"}). In addition to new DNA polymerases evolving to perform DNA damage responses, the function of existing polymerases appears to have shifted during metazoan evolution from involvement in the DNA damage response to the diversification of Ig V genes.

Contribution of Polη, Polν, and Polθ to TLS past abasic sites
-------------------------------------------------------------

In addition to the DNA synthesis step of Ig gene conversion, the following data suggest that Polν and Polθ may carry out TLS past abasic sites in Ig V hypermutation in DT40 cells. *POLN^−/−^/POLQ^−/−^* cells showed a significant reduction in the number of C to G mutations in comparison with wild-type cells. In addition, *POLH^−/−^/POLN^−/−^/POLQ^−/−^* cells showed 3.5 times lower total number of mutations in comparison with wild-type cells. Therefore, we conclude the involvement of these three DNA polymerases in nontemplated Ig V hypermutation in DT40 cells ([Fig. 1](#fig1){ref-type="fig"}). It should be noted that the role of TLS in Ig V hypermutation in human and mouse B lymphocytes is unclear. In other words, although several studies demonstrate the role of TLS polymerases in murine Ig V hypermutation ([@bib25]; [@bib24]; [@bib12]; [@bib45]), it is unclear whether TLS polymerases carry out DNA synthesis on intact template strands or bypass unknown DNA lesions to accumulate mutations.

DT40 cells deficient in Rev1, another TLS polymerase, exhibit a 75% drop in the number of Ig V hypermutation events in comparison with wild-type cells, indicating a higher contribution of Rev1 to Ig V hypermutation compared with Polη, Polν, and Polθ ([@bib40]). Intriguingly, Polθ contains the Rev1-interacting motif x-x-x-F-F-y-y-y-y (x, no specific residue; y, no specific residue but not proline), which is conserved among species (three motifs in human and chicken and four motifs in mouse; [@bib32]). The biological significance of possible interactions between Rev1 and Polθ should be elucidated in the future.

The data of nontemplated mutations do not completely agree with biochemical studies of Polν and Polθ. Although only Polθ, but not Polν, can efficiently bypass abasic sites in vitro ([@bib46]), our study indicates the contribution of both DNA polymerases to this bypass reaction in vivo ([Fig. 3 A](#fig3){ref-type="fig"}). Furthermore, although in vitro studies predict that a defect in Polθ causes reduction in C to T and G to A transition mutations ([@bib48]), this prediction is not verified by the spectrum of nontemplated mutations in our study ([Fig. 3 A](#fig3){ref-type="fig"}). This is also the case with *POLQ*-deficient mice, which show ambiguous results on Ig hypermutation, making it difficult to conclude whether Polθ is involved in Ig hypermutation ([@bib61]; [@bib25]; [@bib24]). Purified Polν is an extremely low fidelity enzyme incorporating T opposite template G with a frequency of 0.45 ([@bib56]; [@bib3]), whereas C to T or G to A transition mutations are not significantly decreased in the absence of Polν in this study ([Fig. 3 A](#fig3){ref-type="fig"}). However, it should be noted that some C to T and G to A transitions might be derived from nonprocessed uracil (simply generated by AID), which instructs template T and may be bypassed by many polymerases and not just Polν and Polθ. In contrast with these discrepancies, Polη-mediated preferential incorporation of A opposite abasic sites in vitro ([@bib20]; [@bib62]) is in agreement with the decreased number of C to T or G to A transition mutations caused by the loss of Polη in *POLN^−/−^POLQ^−/−^* cells ([Fig. 3 A](#fig3){ref-type="fig"}). Further studies are required to discuss the relevance of in vitro studies to TLS in vivo because of complex functional interactions among multiple polymerases.

Materials and methods
=====================

Cell culture and DNA transfection
---------------------------------

DT40 cells were cultured in RPMI 1640 medium supplemented with 10 µM β-mercaptoethanol, 10% fetal calf serum, and 1% chicken serum (Sigma-Aldrich) at 39.5°C ([@bib54]). 10^7^ cells were suspended in 0.5 ml PBS containing 10--30 µg linearized plasmid for each transfection and electroporated with a gene pulser apparatus (Bio-Rad Laboratories) at 550 V and 25 mF. After electroporation, cells were transferred into 20 ml fresh medium and incubated for 24 h. Cells were resuspended in 80 ml medium containing the appropriate drugs and divided into four 96-well plates. After 7--10 d, drug-resistant colonies were transferred to 24-well plates ([@bib8]).

Measurement of targeted integration frequencies
-----------------------------------------------

To analyze integration events at the *OVALBMIN* locus and *POLK* locus, targeted construct DNAs were transfected into cells, and Southern blot analysis was performed after selection of clones resistant to the appropriate antibiotics ([@bib8]).

Generation of gene-disrupted cells
----------------------------------

We transiently expressed Cre-ER and exposed *POLN^−/−^* and *POLN^−/−^/POLQ^−/−^* cells to 4-hydroxytamoxifen (OH-TAM) to delete the *POLN-bsr*,*POLN-hisD*, *POLQ-neo*, and *POLQ-puro* marker genes, which were flanked with loxP sites. The resulting *POLN^−/−^* and *POLN^−/−^/POLQ^−/−^* cells were sequentially transfected with *POLH-puro* and *POLH-bsr* targeting constructs to obtain *POLH^−/−^/POLN^−/−^* and *POLH^−/−^/POLN^−/−^/POLQ^−/−^* clones, respectively ([@bib17]; [@bib60]). To express human *POLN* in *POLN^−/−^* cells, human cDNA was inserted into expression vector containing the *puro* selection marker gene ([@bib56]).

Proliferation analysis
----------------------

Cells were counted using a hematocytometer, and cells were diluted to 10^5^/ml in 5 ml medium every 24 h. Next, we calculated the relative cell number.

Colony formation assay
----------------------

Serially diluted cells were plated onto 6-well plates with 5 ml/well 1.5% (wt/vol) methylcellulose (Sigma-Aldrich) containing Dulbecco's modified Eagle's medium/F-12 (Invitrogen), 15% fetal calf serum (Equitech-Bio), 1.5% chicken serum (Sigma-Aldrich), and 10 µM β-mercaptoethanol and were incubated at 39.5°C for 6--7 d. For exposure of cells to cisplatin (cis-platinum \[II\] diaminodichloride; Nihon-Kayaku), 10^5^ cells were incubated at 39.5°C in 1 ml complete medium containing cis-platinum (II) diaminodichloride for 1 h. Cells were plated onto 6-well plates with 5 ml/well 1.5% (wt/vol) methylcellulose-containing medium and were incubated at 39.5°C for 7--10 d. To measure the sensitivity to camptothecin, cells were plated in methylcellulose medium containing camptothecin and were incubated at 39.5°C for 7--10 d ([@bib33]; [@bib19]).

Chromosomal aberration analysis
-------------------------------

To measure spontaneous chromosomal aberrations, cells were incubated with 0.1 mg/ml colcemid for 3 h before fixation to enrich mitotic cells. Harvested cells were treated in 75 mM KCl for 15 min at room temperature and fixed in 5 ml freshly prepared 3:1 mixture of methanol/acetic acid. Cell suspension was dropped onto a wet glass slide with 50% ethanol and immediately flame dried. The slides were treated with 3% giemsa solution in 50 mM phophate buffer, pH 6.4 (3.36 g/liter KH~2~PO~4~ and 2.78 g/liter Na~2~HPO~4~). They were rinsed carefully with water from the opposite site of the sample, air dried, covered with cover glass, and observed on microscope oil (1,000× magnification; [@bib54]).

Measurement of recombination frequencies using ISceI-induced DSB repair
-----------------------------------------------------------------------

Modified SCneo was inserted into the *OVALBUMIN* gene construct and targeted into the *OVALBUMIN* locus in wild-type, *POLN^−/−^*, *POLQ^−/−^*, and *POLN^−/−^/POLQ^−/−^* DT40 cells. In transient transfections, 5 × 10^6^ cells suspended in 0.5 ml PBS were mixed with the following plasmid DNAs without linearization: 10 µg pBluescript SK plus 10 µg ISceI expression vector (pCBASce). 20 µg pBluescript II KS was used as a negative control.

Cells were grown for 7--10 d, and HR frequencies were calculated using the following equation: HR frequency (colonies/cell) = number of G418-resistant colonies/plating efficiency of transfected cells in the absence of G418 ([@bib18]). We obtained and counted colonies in each sample to calculate a mean value and standard error.

Generation of AID expression retrovirus and infection into DT40 cells
---------------------------------------------------------------------

For retrovirus infection, the pMSCV-IRES-GFP recombinant plasmid was constructed by ligating the 5.2-kb BamHI--NotI fragment from pMSCVhyg (Takara Bio Inc.) with the 1.2-kb BamHI--NotI fragment of pIRES2-EGFP (Takara Bio Inc.). Mouse AID cDNA was inserted between the BglII and EcoRI sites of pMSCV-IRES-GFP. The plasmids were transfected into the packaging cell line by FuGENE reagent (Roche). Preactivated cells were suspended at a density of 4 × 10^6^ cells/ml in the medium containing retrovirus supplemented with 16 mg/ml polybrene (Sigma-Aldrich), centrifuged at 3,000 rpm for 45 min at 32°C, and incubated for 48 h ([@bib52]). The efficiency of infection was \>80%, as judged by GFP expression using FACS. Cells were subcloned into 96-well plates 2 d after infection, and after 2 wk, GFP-positive clones were selected by FACS analysis.

Analysis of AID-induced Ig hypermutation and Ig gene conversion at VJ~λ~ segments
---------------------------------------------------------------------------------

DNA was extracted from more than three clones each of wild-type, *POLQ^−/−^*, *POLN^−/−^*, and *POLN^−/−^/POLQ^−/−^* cells at 2 wk after subcloning ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.200912012/DC1)). PCR-amplified fragments of V~λ~ segments were cloned into plasmid and subjected to base sequence analysis. The rearranged VJ~λ~ was amplified using the CVLF6 (5′-CAGGAGCTCG­CGGGGCCGTCA­CTGATTGCCG-3′) and CVLR3 (5′-GCGCAAGCTT­CCCCAGCCTGC­CGCCAAGTCCAAG-3′) primers as previously described ([@bib44]). After purification with a gel extraction kit (QIAquick; QIAGEN), PCR products were cloned into the TOPO pCR2.1 cloning vector (Invitrogen) and sequenced with the M13 forward or reverse primer and a sequencer (ABI PRISM 3100; Applied Biosystems). Sequence alignment with GENETYX-MAC (Software Development) allowed the identification of changes from the consensus sequences in each clone. Frequencies of Ig hypermutation, ambiguous mutations, and Ig gene conversion were determined as previously described ([@bib44]). In brief, all sequence changes were assigned to one of three categories: Ig gene conversion, nontemplated point mutation, or an ambiguous category. This discrimination rests on the published sequences of the V~λ~ pseudogenes that could act as donors for gene conversion. For each mutation, the database of the V~λ~ pseudogene was searched for a potential donor. If no pseudogene donor containing a string of \>9 bp could be found, the mutation was categorized as a nontemplated point mutation. If such a string was identified and there were further mutations that could be explained by the same donor, all of these mutations were assigned to a single long-tract gene conversion event. If there were no further mutations, it was possible that the isolated mutation could have arisen through a conversion mechanism or could have been nontemplated and was therefore categorized as ambiguous.

The rate of hypermutation and Amb mutation was calculated using the following equation: rate of mutation = mutation frequency/length of sequenced Ig light chain locus (430 bp)/sequenced sample numbers/number of cell divisions (42 cycles for wild-type, 37 cycles for *POLH^−/−^*,*POLN^−/−^*,*POLQ^−/−^* single-gene--disrupted clones, 34 cycles for *POLN^−/−^/POLQ^−/−^* double-mutant cells, and 26 cycles for *POLH^−/−^/POLN^−/−^/POLQ^−/−^* triple-mutant cells for 14 d). The rate of Ig gene conversion was calculated using the following equation: rate of gene conversion = gene conversion frequency/sequenced sample numbers/number of cell divisions.

Analysis of the rate of sIgM gain
---------------------------------

The generation frequency of sIgM gain revertants was monitored by flow cytometric analysis of cells that had been expanded for 3 wk after subcloning and stained with FITC-conjugated goat anti--chicken IgM (Bethyl Laboratories, Inc.). To enhance Ig gene conversion, 1.25 ng/ml TSA was added to the sIgM-negative cell populations, and the fraction of sIgM-positive revertants was monitored over time as described previously ([@bib50]).

Nucleotide sequence analysis of rearranged VJ~λ~ segments derived from sIgM gain fractions
------------------------------------------------------------------------------------------

Fractions of three independent sIgM gain revertants were obtained from each genotype using MACS separation columns (Miltenyi Biotec; Fig. S2). Genomic DNA was amplified by PCR with Pyrobest DNA polymerase (30 cycles of 94°C for 30 s, 60°C for 1 min, and 72°C for 1 min). The rearranged VJ~λ~ was amplified using the CVLF6 (5′-CAGGAGCTCG­CGGGGCCGTCA­CTGATTGCCG-3′) and CVLR3 (5′-GCGCAAGCTT­CCCCAGCCTGC­CGCCAAGTCCAAG-3′) primers as previously described ([@bib44]). After purification with a gel extraction kit (QIAquick), PCR products were cloned into the TOPO pCR2.1 cloning vector and sequenced with the M13 forward or reverse primer and a sequencer (ABI PRISM 3100). Sequence alignment with GENETYX-MAC allowed the identification of changes from the consensus sequences in each clone. Frequencies of Ig hypermutation and Ig gene conversion were determined as previously described (see Analysis of AID-induced Ig...).

Online supplemental material
----------------------------

Fig. S1 shows the V~λ~ sequence alignment of wild-type, *POLQ^−/−^*,*POLN^−/−^*, and *POLN^−/−^/POLQ^−/−^* clones before TSA treatment. Fig. S2 shows the number of subclones and sequences analyzed in individual experiments. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200912012/DC1>.
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